Abstract: MERTK plays an important role in cell biology and is correlated with many cancers, such as mantle cell lymphomas, pituitary adenomas, and T-cell acute lympholoblastic leukemia. So identification of new MERTK inhibitors is of extreme importance. In this study, 107 MERTK inhibitors with known activities were gathered to generate a ligand-based pharmacophore model (ADDHH.4), followed by building a 3D-QSAR model, which had high value of coefficient of determination (R 2 =0.9061) and high value of coefficient of determination (Q 2 =0.7442). For the pharmacophore model, two hydrogen bond donors (D), one hydrogen bond receptor (A), and two hydrophobic groups (H) were considered as the key elements contributing to ligand activity. The model then served to search a drug-like database with 1.5 million molecules, and 47832 hits were obtained. Subsequently, docking procedure was applied on these hits, and 840 compounds were obtained through high-throughput virtual screening (HTVS). Standard precision (SP), extra precision (XP) and rule of five were also used in virtual screening protocol. Finally, six candidates were identified as potential MERTK inhibitors, with the docking mode in MERTK analyzed.
INTRODUCTION
MERTK, also called Mer, a member of the TAM (Tyro3, Axl and Mer) family of receptor tyrosine kinases (RTK), has complex and diverse roles in cell biology. It behaves as a proto-oncogene, having many roles in cellular transformation of NIH/3T3 and B-lymphocytes cells [1, 2] . Abnormal activation or over-expression of MERTK has been implicated in neoplastic progression of many human cancers and has been correlated with poor prognosis including pituitary adenomas, mantle cell lymphomas, and T-cell acute lymphoblastic leukemia [3] [4] [5] [6] [7] . For example, acute lymphoblastic leukemia (ALL) is the most common malignancy among children and represents nearly 30% of all the pediatric cancers [8] . However, extensive exposure to current chemotherapeutic regimens is associated with toxic side effects (growth slowing, organ damage, and secondary malignancy) and development of chemoresistance [9] . It is obvious that the role of MERTK is of much importance and developing Mer inhibitors may be an effective way to prevent and treat these diseases.
MERTK is a transmembrane receptor tyrosine kinase with extracellular immunoglobulin and fibronectin-like domains that recognize ligands, such as growth arrest specific 6 (Gas6) and protein S [10] [11] . So far, there are seven crystallographic structures of MERTK, which can be downloaded from PDB database. Some of them are combined with cofactors, while others are crystallized with *Address correspondence to this author at the College of Chemical Engineering, Sichuan University, Sichuan, Chengdu 610065, China; Tel: +86 028 85405221; Fax: +86 028 85405220; E-mail: zhoulu@scu.edu.cn weak inhibitors. Analysis of those crystal structures of MERTK indicates that it has an active cavity surrounded by a series of hydrophobic amino acid residues, such as (LEU593-VAL601-ALA617-ILE650-LEU671-PRO672-PHE673-MET674-TYR676-TYR685-ALA740) in the scope of 3Å. Positive charged residues (ARG727-ARG758) and negative charged residues (ASP741-ASP678) are also in 3 Å. Now, quite a few inhibitors of MERTK were reported. For example, compound-OLP (ZINC ID:ZINC02391782) was a weak MERTK inhibitor and the IC 50 was 11 μM [12] . Because of its limited potency and poor selectivity, discovering novel inhibitors with high efficiency is urgent and necessary. Based on the structure of compound-OLP and its interaction with MERTK, some new inhibitors have been designed and synthesized [13] .
In the present study, a ligand-based pharmacophore model was developed on the basis of a series of MERTK inhibitor structures with known activity. Then, a pharmacophore-based three dimensional-quantitative structure activity relationship (3D-QSAR) model was obtained. To screen from the drug-like database and discover MERTK inhibitors with new scaffold, the pharmacophore model was used in searching hits matched with all the pharmacophoric features. Subsequently, docking procedure and Lipinski's rule of five were adopted to screen these hits [14] . Restrictive docking was applied in all docking procedures. Finally, six candidate compounds were considered as potential MERTK inhibitors, with the binding mode of MERTK and their ADME analyzed.
MATERIALS AND METHODS

Data Collection
A dataset, consisting of 107 small molecules (ligands), was prepared for current study, and their 2D structures have been listed in Table 2 . The dataset contained three kinds of molecular scaffolds, pyrazolopyrimidine, pyridinepyrimidine and substituted-pyrimidine. 2D structures and IC 50 values of these molecules were obtained from three different literatures. The inhibitory activities had a wide range of 0.15-28,000 nM. IC 50 , the dose of molecule required for 50% inhibition of MERTK, was determined through the same method (Microfluidic Capillary Electrophoresis (MCE) Assay) [14] [15] [16] . In the current study, pIC 50 values were required in 3D-QSAR mode generation to get linear relationship for all computations, which were converted from the IC 50 values.
To generate common pharmacophore, the value of activity threshold was set. Ligands exhibiting pIC 50 values above 8.4 were considered as active molecules, while the ones below 6.0 were considered as inactive. Naturally, others between 6.0 and 8.4 were moderately active molecules. So it turned out that 17 molecules were assigned to active set and were equal to a number of ligands in the inactive set.
Ligand and Protein Preparation
3D structures of the 107 inhibitors were drawn using ChemBiOffice 2010 and prepared by LigPrep (Schrödinger 2012). The main function of LigPrep was to produce 3D structures with low energy by generating stereoisomers, specifying the appropriate ionization state, adding hydrogen and adding charge, which was recommended for programs such as Glide and QikProp. OPLS_2005 force field was chosen for the minimization of structures, and the ionization state was generated at pH value of 7.0±0.2. We utilized the computation of retained specified chiralities. As a result, a small amount of stereoisomers was produced as prepared ligands.
MERTK crystallographic structures were downloaded from the PDB database. The structure(PDB ID: 4MHA), cocrystallizied with a comparatively larger and better activity inhibitor, was preferred and selected, since it provided a more suitable space when generating receptor grids than those co-crystallized with smaller inhibitors. The 4MHA was prepared using the protein preparation wizard of Schrödinger which amended the structure of the protein. In the preparation, the bond orders were assigned to all bonds in the structure. Its original hydrogens were removed and new hydrogens were added to all bonds. Filling for the missing side chains and missing loops was carried out using prime. Water molecules were deleted, and minimization was done using the OPLS_2005 force field [17] .
A receptor grid box (enclosed box), which must be used in docking procedure, was generated during the protein preparation in Glide module [18] . According to the center and the size of the co-crystallized ligand molecule, the position and scope of the box was calculated and determined. As the co-crystallized ligand molecule was selected as a reference position, all docked molecules must be limited in the enclosed box. Since the size of molecule to be docked was not known, a relatively large grid space of 15 Å was set up.
Docking Procedure
Glide is a software package in Schrödinger designed for docking procedure. It has three different docking precisions, high-throughput virtual screening (HTVS), standard precision (SP) [19, 20] , and extra precision (XP) [21] . HTVS is appropriate for rapidly docking jobs of very large numbers of molecules and it restricts conformational sampling compared with SP. SP is suitable for docking jobs of large numbers of ligands, taking more time than HTVS. XP is the most formidable procedure of the three docking precisions in screening and discriminating ligands, while the time required is much longer than SP. In this work, we carried out HTVS to molecules first, followed by SP to the molecules successfully passed, finally come the XP. For docking parameters, ligand sampling was flexible. Sampling nitrogen inversions and sampling ring conformations were checked. The scaling of van der waals radii and other parameters was set as default values.
The prepared ligands were then subjected to generating conformer in the Macromodel module of Schrödinger using a Macromodel torsion angle search approach. OPLS_2005 was employed as force field for minimization of returned conformers with solvent using None, "Electrostatic Treatment" using Distance-dependent. Generated conformers were then applied to docking procedure with MERTK crystallographic structure (PDB ID: 4MHA) using PS. The top 5 poses of each molecule according to the glide score were subsequently docked to 4MHA with XP. The best conformer with the highest glide score of each one ligand was chosen as representative one for pharmacophore generation step.
Before conformers docking, The crystallographic ligand was re-docked in 4MHA active cavity, and the Root Mean Square Deviation (RMSD) was 0.727 Å (Fig. 1) . It manifested the accuracy of our docking procedure. In the figure, yellow inhibitor is the re-docked ligand, while the purple one represents crystallized conformer. As shown in Fig. (1B) , the portions with benzene stretching out of the active pocket are almost completely overlapped. Although the parts with alkyl chain reaching to back of the active cavity and the naphthenic sections at right of the pocket are not entirely aligned, they are nearly overlapping. The two parts of ligand are in the hydrophobic area encircled by those residues (LEU671-ILE650-ALA740-MET730). When combined with Fig. (1A) , it is clear that PHE673 at left of the cavity, LEU593 at roof, MET730 below, and ILE650 at back of the pocket compose a large hydrophobic area. Other hydrophobic residues such as LEU671 and ALA740 also lie at back of the pocket.
Generation of Common Pharmacophore Hypotheses
Pharmacophore Alignment and Scoring Engine (PHASE) is a versatile tool that is helpful in pharmacophore generation, structural alignment, 3D database creation, activity prediction and ligand-based virtual screening [22] . In other words, it is a useful tool for 3D chemical features identification and, critical for the biological activity of a compound. Generating pharmacophore hypothesis involves the following steps: preparing ligands, creating sites, finding common pharmacophore, scoring hypotheses and building QSAR model. The Phase package of Schrödinger suite 9.3 is used to perform Pharmacophore hypothesis in this study. It has six pharmacophore features, called hydrogen bond acceptor (A), hydrogen bond donor (D), hydrophobic group (H), negatively charged group (N), positively charged group (P), and aromatic ring (R) [23] .
When creating sites, the maximum and minimum number of pharmacophore sites were both variant from three to seven. Firstly, we assigned the sites number and the number of active ligands required to match the resulting hypotheses. The parameters in feature frequencies table were set as default. Then we began to find common pharmacophores. The found hypotheses were subjected to hypotheses scoring. If no one passed score step, the parameters were changed and the generated hypotheses were scored once again. This process was cycled until at least one hypothesis was successfully generated and scored. To match the number of pharmacophore points, finally, 6 and 5 were set as the maximum and minimum point, respectively. In addition, the number of the active ligands that must match the subsequently generated variant was set as 15. In this step, conformers of the active ligands supplied a set of pharmacophore features, which were involved in the hypotheses.
In the scoring step, we appraised the quality of the generated pharmacophores with scoring algorithms, which related to the alignment between the pharmacophore hypothesis and the ligands used in generation. The parameters for scoring actives, scoring inactives and rescoring were set as default. The active scoring was to evaluate the alignment of the pharmacophore with the active ligands; namely a higher score indicated a better alignment and an optimum pharmacophore hypothesis. Similarly, the inactive survival score was to evaluate the alignment of the pharmacophore hypothesis with the inactive ligands, but a higher score indicative of a poor hypothesis. Normally, the scoring process contains discovering of pharmacophore hypotheses with optimum alignment, elimination of those with poor alignment. Finally the pharmacophore hypotheses which survived the scoring process were sorted according to their score. Only the pharmacophore hypotheses with high scores were qualified for the next step.
3D-QSAR Model Generation
3D-QSAR is a powerful tool to explore interaction between ligands and their targets and speculate activity for new inhibitors. It utilizes a computational method that research the relationship between small molecules structures and their biological activities against a target [24] . The obtained pharmacophore hypotheses mentioned above just demonstrated the alignment between the pharmacophore sites and the inhibitors. However, the relationship between alignment and activity of a inhibitor was not clear. Thus, the 3D-QSAR models were built to analyze this relationship and verify those pharmacophore hypotheses on the basis of Partial Least Squares (PLS) regression. It is suitable for a series of independent binary variables, which are derived from the cubic grids partitioned from the volume of the ligands parmacophore features in the training set. Each cube was assigned to a set of bit values (0 or 1) to represent different features [25] .
There are two different QSAR models in Phase: atombased model and pharmacophore-based model. The atombased model uses a van der Waal model of atoms and takes all atoms of a molecule into consideration. It is often very useful in special cases, features such as steric clashes, but not the pharmacphore features are of importance. So we chose the pharmacophore-based one to build 3D-QSAR model for the previously selected pharmacophore hypotheses.
During verification of pharmacophore hypotheses and QSAR model, the activity of training set ligands that were used to develop a QSAR model and the activity of test set ligands which were not considered when building the QSAR model were predicted. The reliability and predictive power of the QSAR model was examined by the following parameters. For training set, coefficient of determination (R 2 ) and variance ratio (F), statistically significant for the model, were mainly inspected. Similarly, cross-validated value (Q 2 ) and Pearson correlation coefficient (Pearson-R) were examined primarily, since they determined the reliability for the prediction of the external molecules in test set. Other parameters, such as standard deviation of the regression (SD) and root mean squared error (RMSE) were also used as criterion.
Among the 107 molecules, 29 were picked out as test set, and the rest served as training set. The scope of ranked activity data was divided into multiple small sections, among which one or two ligands were adopted in the test set molecules. By doing this, we insured that the activity data distribution of training set and test set were basically identical. Then, a pharmacophore-based QSAR model was generated by a Partial Least Squares (PLS) regression. It was helpful in predicting activities of molecules matched a pharmacophore hypothesis. The 3D-QSAR model was built with PLS factors varied 1 to 5 and the predictive ability enhanced with an increasing number of PLS factors.
Pharmacophore-Based Virtual Screening
The pharmacophore model built was then adopted to search a database of 1.5 million molecules, which were from ZINC database, namely "Natural Droduct Database", "Asinex Database", "Maybridge Database", "Ibs Database", "Specs Database" and, DrugBank Database namely "DrugBank-Small Molecule Drugs Database" [26, 27] . Before virtual screening (VS), molecules were prepared by LigPrep, as mentioned in the ligands preparation chapter. For comformers generation, we specified that the conformers were generated with existing conformers eliminated during screening, because different comformers of a same structure would occasionally result in significant discrepancy in alignment with the pharmacophore. The maximum number of conformers for a rotatable bond was set to 10. The maximum number of conformers for each structure was set to 100. The sampling option was "Thorough" and the conformers with energy exceeding 10.0kal/mol were abandoned. The structures with rotatable bonds more than 15, were skipped during conformer generation. The intersite distance was set within 2.5 Å. Required matched site points was set to 5. The hits with vector score less than -1.0 or volume score less than 0.0 was abandoned. Only one hit could be returned per structure. The resulting hits were sorted by fitness determined by alignment score, vector score and volume score.
The drug candidates needed further filtration. We used Lipinski's rule of five to eliminate the ones that matched the pharmacophore hypothesis but did not have drug-like properties. It included partition coefficient (QPlogPo/w), Hydrogen-Bond Donor (donorHB), Hydrogen-Bond Acceptor (accptHB), rotatable bonds (rotor), and molecule weight (molMW). These pharmarceutically relevant properties determined the transportation of drug and the dynamic change rule after taking a medicine. The values of these pharmacokinetic parameters were calculated by the Qikprop package of Schrödinger suite. Molecules just within the following scopes could be preserved: -2≤QPlogPo/w≤6.5, donorHB≤5, accptHB≤10, rotor≤10, and 150≤molMW≤500.
RESULTS AND DISCUSSIONS
In order to discover inhibitors with new skeleton for MERTK using computer method, several pharmacophors were produced based on the 107 inhibitors. Among them, the best suitable common pharmacophore was selected and estimated through the 3D-QSAR model analysis. The pharmacophore model and 3D-QSAR model were used to search the database, find matched hits, and predict activity. The final candidates, through the selection of the following conditions, including score, predicted activity, rule of five, and glide docking score, were considered as the potential MERTK inhibitors. In addition, the binding model between MERTK active site and those possible inhibitors were analyzed by docking method.
Pharmacophore Sites Alignment Analysis
According to what mentioned above, 77 variants were produced. But just 9 of them was successfully found and scored with results listed in Table 1 , which were ranked by survival active scores. They were two pharmacophores of ADHHH, two ADHHR, and five ADDHH hypotheses. We abandoned those with three or four sites, because the fivepoint hypotheses were considered more powerful in representing the features of the MERTK inhibitors. Moreover, three or four featured pharmacophores with low value of survival score would probably screen out less active compounds in the following database screen step. From Table 1 , ADDHH4 was not the top one, but the highest ranked ADHHH ones were proved with poor prediction of activity in 3D-QSAR validation. Thus, ADDHH4 was chosen as the best one for further exploration, of which the survival active score was 3.283(relatively high), survival inactive score 1.716(relatively low). What constitute this five point pharmacophore are that, two hydrogen bond donor (D), one hydrogen bond receptor (A), and two hydrophobic groups (H). The intersite distance and angles between each pharmacphoric features are illustrated in Fig. (2) . We can separate this five-point model into two parts. Two hydrophobic groups (H10 and H11), hydrogen bond receptor (A2) and the vicinity hydrogen bond donor (D6) almost in the same plane are considered as one domain. Another domain merely contains hydrogen bond donor (D5), the polar group far from the pyrimidine ring. The alignment of the most active and inactive ligand with ADDHH4 is depicted in Fig. (3) . From Fig. (3A) , the secondary amine (NH) contributes to the remaining hydrogen bond donor (D6), and the nitrogen atom at the outer edge of the pyramidine ring contributes to the only hydrogen bond receptor (A2). The carbon chain attached to the secondary amine position and the lipophilic carbon ring act as the two hydrophobic groups (H), respectively. They are in the big hydrophobic pocket formed by residues Leu593, Phe673 and Met730, when docked against the 3D structure of MERTK, which will be mentioned later. Based on comparison between Fig. (3A) with Fig. (3B) , the superposition of ADDHH.4 with the most active compounds 1 and the least active compounds 107, it is obvious that compounds 1 has a favourable mapping with ADDHH4 while compounds 107 does not. This was in line with what revealed by the survival active score and the survival inactive score.
In this study, six compounds from the data pool are ultimatly identified as inhibitors with new skeleton against MERTK after pharmacophore-based virtual screening and docking analysis. Alignment of the six with ADDHH.4 is illustrated (Fig. 4). 
3D-QSAR Validation
Aiming at developing 3D-QSAR model for the generated pharmacophore, all the 107 ligands were divided into training set (78 ligands) and test set (29 ligands). The detail information, including experimental activity and predictive activity, was displayed in Table 2.   (Table 2) The 3D-QSAR model containing one to five PLS factors was generated for all successfully scored pharmacophores, while only the ADDHH.4 was considered as an outstanding, partly because of the high survival active score and low survival inactive score, partly because of the 3D-QSAR results. The parameters of ADDHH.4 and other pharmacophores with PLS factor of five were reported in Table 3 . The ADDHH.4 with PLS factor of five showed better performance when compared with other hypotheses. It has a high value of coefficient of determination (R2=0.9061) and variance ratio (F=139), low value of standard deviation of the regression (SD=0.3558) and statistical significance (P=1.523e-035), suggesting that it was a statistically significant regression with a great degree of confidence. The prediction of training set was a perfect one. Similarly, the test set revealed expected better parameters, high value of cross-validated value (Q2=0.7442) and Pearson correlation coefficient (Pearson-R=0.873), low value of root mean squared error (RMSE=0.6057), demonstrating that the prediction of test set was credible. Additionally, the correlation graphs between actual pIC 50 and 3D-QSAR model predictive pIC 50 was drawn in Fig. (5) . It described a close relationship between them, providing further evidence that this 3D-QSAR model was statistically significant and strongly effective in predictive ability. What was worth noting, depicted in the scatter plot (Fig. 5) and Table 2 ). But, the distinctions were actually no more than one order of magnitude. So, these error values were reasonably within an acceptable range. Fig. (5) . Graphs of actual vs predicted activitys of training set (above) and test set (below).
Pharmacophore-Based Virtual Screening
ADDHH.4, the best pharmacophore, was applied to carry out searching among the 1.5 million molecules. As mentioned above, we utilized pharmacophore screen as first criterion to eliminate molecules that did not match the hypotheses. The returned hits were required to satisfy all the five pharmacophore features within the intersite distance matching tolerance. It was the tolerance on features in a hit to the pharmacophore features, which was set to 2.5 Å. Secondly, fitness score, which carried a linear relationship with alignment score, vector score and volume score, was used as a cutoff to reduce the hits list. It was a measurement of the matched-degree between a hit and a pharmacophore as a whole. We refused the molecule whose fitness score was below 1.0. In addition, the Lipinski rule of five was applied for those obtained small molecules. As a result, the compounds list was reduced to 47832 hits.
Docking Analysis
After pharmacophore-based screening, all the retrieved hits possessed the required five features. But, the occurrence of the possible interaction of a hit with MERTK was not known. So, docking procedure must be executed to supplement the pharmacophore-based screening and to reject the compounds that matched five features while performed no interaction or bad interaction with the target. It is to differentiate active and inactive molecules, also to visualize intermolecular interactions between the final hits and their receptor.
In the previous chapter of docking, we have docked conformers of all the 107 compounds into MERTK active site to choose the best structure for every molecule entering into pharmacophore hypotheses generation step. Meanwhile, we discovered that each structure without exception formed two same hydrogen bonds with the receptor active pocket: one with the hinge region residue Met674, another with residue Pro672. It was consistent with what was illustrated by previous work that hydrogen bonds between an effective ligand with residue Met674 and residue Pro672 were essential and crucial [11, 13] . This straightforwardly made restricted docking feasible. Thus, before the docking screening step, we readjusted the MERTK receptor grid box and residue Met674 and residue Pro672 were set as two restrictive conditions. A qualified inhibitor must form hydrogen bonds with these two residues. In addition, it was discovered from the conformations docking result that many of the 107 ligands bonded with one or two of the three residues: Asn728 and Arg727 and Asp678, via hydrogen bonds. Also, the re-docking of the crystallized ligand was processed and the veracity of the docking procedure was verified.
The HTVS mode of Glide was firstly used to filter the candidates that were incapable in establishing connection with the active site. 47832 hits through pharmacophorebased screening, rapidly dropped to 840 after the HTVS procedure, because compounds that had no interaction with residue Met674 and residue Pro672 were eliminated by restricted docking effectively. Subsequently, the SP mode of Glide was utilized to accomplish the farther work :namely, the 840 compounds were docked into the binding cavity again. In this way, Glide score of these structures were examined and those with score inferior to -5.0 were rejected. As a consequence, 109 hits returned. Finally, the hits were subjected to the XP mode of Glide. During this process, not only did the Glide score play a key role, but also the binding mode was taken into consideration. Ultimately, six compounds from the data pool were identified as potential inhibitors with new skeleton against MERTK. Binding mode visualizations of the six were shown in Fig. (6) , while 2D structures of them were shown in Fig. (7) . As shown in Fig.  (7) , the six hits revealed a diversity of structure. This further demonstrated the dependability of our pharmacophore that it could recognize active inhibitors with various structures for MERTK.
The first two hits in Fig. (6) were chosen as representatives to analyze the binding mode. For ZINC09421648, as described in Fig. (6A) , the imino group in the pyrazole ring acted as H-bond donor and forms a hydrogen bond with residue Pro672 with bond length 2.121 Å. Similarly, the hydroxyl, located at the single benzene ring, bonds to ARG727 via a hydrogen bond with bond length 1.957 Å. Additionaly, O-atom attached to the fivemembered ring, which shared two carbon atoms with the pyrazole ring, acted as H-bond acceptor and interacted with MET674 by a hydrogen bond with length of 1.995 Å. All these hydrogen bonds were short and belonged to strong hydrogen bonds. It indicated that strong interaction existed between this hits and MERTK. Otherwise, methyl group on the pyrazole ring and the single benzene ring as hydrophobic groups interacted with the binding cavity. But, what is unexpected is that the imino group in the indole ring that extended out of the active cavity, also acted as H-bond donor. It made a contribution to the hydrogen bond with LYS675 and the bond length was 2.048 Å. This was not a feature of our pharmacophore. As analyzed above, this hit had all the features required by the pharmacophore and interacted with MERTK at all key persitions satisfactorily. Thus, this unexpected hydrogen bond was considered as a reinforcer of the interaction between ZINC09421648 and MERTK.
For ZINC04656809, the characteristic of binding mode with MERTK has a little difference with the former. For instance, two hydroxyl groups on the single benzene ring are served as two hydrogen-bond donors binding with residues ARG727 and ASP678, with bond length of 1.754 Å and 1.688 Å, respectively. Compared with the features obtained in the pharmacophore hypotheses generation section, the hydrogen bond with residue ASP678 is an unanticipated feature in ADDHH.4. However, as above mentioned, when the collected 107 ligands are applied to dock into the binding pocket of MERTK, many ligands carry the capacity of forming hydrogen bond with one or two of these three residues: Asn728 and Arg727 and Asp678. It is consistent with what illustrated in previous work that Asp678 is of importance for some ligands in forming hydrogen bond with MERTK to increase their inhibitory effect. Analogously, Oatom on the 2-hydroxy-indol ring as H-bond acceptor participated in forming a hydrogen bond with residue MET674 and the imino group as H-bond donor interacted with residue Pro672, with hydrogen bond length of 2.061 Å Fig. (6) . Docking conformation of six identified hits. A is ZINC09421648, B ZINC04656809, C ZINC05818277, D ZINC05939358, E ZINC40312972, F ZINC09375080. Fig. (7) . The 2D structure of the final six hits along with their IDs. 
ADME Prediction of Hits
ADME, pharmarceutically relevant properties, determine the transportation of drug and the dynamic change rule in a body after medicine taking, such as absorption, distribution, metabolism, and excretion (ADME). Predicted octanol/water partition coefficient (QPlogPo/w) value, which is crucial for absorption and distribution of a drug, must be in a reasonable range of -2.0 to 6.5. Predicted aqueous solubility (QPlogS) value is best in a range below -5.0. QPPCaco is deciding element, which estimate cell permeability of a drug in biological membranes. It is poor to range below 25. Crossing the blood-brain barrier (QPlogBB) value was set within an acceptable range of -3 to 1, which is an important precondition for a drug entering into central nervoussystem (CNS).
Hence, we examined those properties. Values of these pharmacokinetic parameters were calculated by Qikprop module and the results were enumerated in Table 4 . As shown in this table embraces partition coefficient (QPlogPo/w) ranges from 1.624 to 3.488, QPlogS from -5.367 to -3.049, QPPCaco from 39.801 to 507.983, and QPlogBB from -2.087 to -0.767. With all these values in acceptable ranges the six hits were likely to exert benign absorption and metabolism.
CONCLUSION
Over-expression of MERTK plays a key role in many cancers, so it is of great importance to identify new inhibitors for treatment of these diseases. In summary, it is our work to find out the significant relationship between important features in structure of known inhibitors and the inhibitory activity, followed by discovery of inhibitors with new scaffold.
A ligand-based pharmacophore was generated using a number of reported inhibitors with known activity against MERTK. It consisted two hydrogen bond donor (D), one hydrogen bond receptor (A), and two hydrophobic groups (H). Followed by this, a pharmacophore-based 3D-QSAR model was developed by using of PLS regression, with various PLS factors. Gratifyingly, the result was attested a statistically significant model (R 2 =0.9061; Q 2 =0.7442). This pharmacophore, therefore, was used to carry out a virtual screening for retrieving new inhibitors in for MERTK. Complementally, molecular docking implemented in this study was applied to analyze the interaction between MERTK and small molecules, to eliminate unreasonable combined hits, to make a comparison between obtained hits and reported inhibitors at the aspect of interacting with MERTK.
After being demonstrated by ADME analysis, six compounds were deemed as potential MERTK inhibitors. So, findings in this study were proved to be useful in optimization and discovery of MERTK inhibitors with new scaffold. 
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